Gamifant (emapalumab)

About Swedish Orphan Biovitrum

Sobi is a premier rare disease company with a mission to pioneer and deliver life-changing therapies for underserved patient populations. The company has established a strong commercial foundation with marketed products in hematology and immunology, complemented by a diversified pipeline of biologics and small molecules. Its strategy hinges on expanding global access, advancing high-potential clinical programs, and maintaining operational excellence to drive sustainable growth and leadership in the rare disease space.

Therapeutic Areas